AMPHET Amphetamines, Presence or Absence 3 NYS qualitative AMPHET Amphetamine Abbott 80% consensus 4 CAP AxSym AMY Amylase +/- 30% 1 CLIA, 2 WLSH, 3 NYS, 6 AAB AMY Amylase AU640 30% 4 CAP AMY Amylase 15 U/L, 15% 7 RCPA AMY Amylase 20% 8 CFX AMY a-Amylase S- 15.7% 5 BV AMY a-Amylase S- 17.7% 5 BV (pancreatic) AMY Amylase -urine U- 30% 2 WLSH AMY Amylase, urine U- AU640 3 SD 4 CAP AMY a-Amylase U- 103.7% 5 BV concentration, random ANA Antinuclear Target value +/- 2 1 CLIA, 3 NYS antibody dilution or (pos. or neg.) AND Androstenedione 2.0 nmol/L 7 RCPA AND Androstendione S- 22.6% 5 BV ANTIDEPRESS Tricyclic Pos/Neg 2 WLSH
AMPHET Amphetamines, qualitative Presence or Absence 3 NYS AMPHET Amphetamine Abbott AxSym 80% consensus 4 CAP AMY Amylase +/- 30% 1 CLIA, 2 WLSH, 3 NYS, 6 AAB AMY Amylase AU640 30% 4 CAP AMY Amylase 15 U/L, 15% 7 RCPA AMY Amylase 20% 8 CFX AMY a-Amylase S- 15.7% 5 BV AMY a-Amylase (pancreatic) S- 17.7% 5 BV AMY Amylase -urine U- 30% 2 WLSH AMY Amylase, urine U- AU640 3 SD 4 CAP AMY a-Amylase concentration, random U- 103.7% 5 BV ANA Antinuclear antibody Target value +/- 2 dilution or (pos. or neg.) 1 CLIA, 3 NYS AND Androstenedione 2.0 nmol/L 7 RCPA AND Androstendione S- 22.6% 5 BV ANTIDEPRESS Tricyclic Pos/Neg 2 WLSH
73_725_65_jadval.docx